These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 37878899)

  • 1. Leptin Increase During Dexamethasone and Its Association With Hunger and Fat in Pediatric Acute Lymphoblastic Leukemia.
    van Hulst AM; Verwaaijen EJ; van den Berg SAA; van Litsenburg RRL; Grootenhuis MA; Fiocco M; Neggers SJCMM; van den Heuvel-Eibrink MM; van den Akker ELT
    J Clin Endocrinol Metab; 2024 Feb; 109(3):631-640. PubMed ID: 37878899
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Physical frailty deteriorates after a 5-day dexamethasone course in children with acute lymphoblastic leukemia, results of a national prospective study.
    Verwaaijen EJ; van Hulst AM; Hartman A; Pieters R; Fiocco M; Pluijm SMF; van Litsenburg RRL; Grootenhuis MA; van den Akker ELT; van den Heuvel-Eibrink MM
    Cancer Med; 2023 Dec; 12(24):22304-22315. PubMed ID: 38069550
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Short-term effects of prednisolone and dexamethasone on circulating concentrations of leptin and sex hormone-binding globulin in children being treated for acute lymphoblastic leukaemia.
    Wallace AM; Tucker P; Williams DM; Hughes IA; Ahmed SF
    Clin Endocrinol (Oxf); 2003 Jun; 58(6):770-6. PubMed ID: 12780755
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of maintenance therapy on sleep-wake rhythms and cancer-related fatigue in pediatric acute lymphoblastic leukemia.
    Steur LMH; Kaspers GJL; van Someren EJW; van Eijkelenburg NKA; van der Sluis IM; Dors N; van den Bos C; Tissing WJE; Grootenhuis MA; van Litsenburg RRL
    Support Care Cancer; 2020 Dec; 28(12):5983-5993. PubMed ID: 32285260
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hydrocortisone to reduce dexamethasone-induced neurobehavioral side-effects in children with acute lymphoblastic leukaemia-results of a double-blind, randomised controlled trial with cross-over design.
    van Hulst AM; van den Akker ELT; Verwaaijen EJ; Fiocco M; Rensen N; van Litsenburg RRL; Pluijm SMF; Zwaan CM; van Santen HM; Pieters R; Evers AWM; Grootenhuis MA; van den Heuvel-Eibrink MM
    Eur J Cancer; 2023 Jul; 187():124-133. PubMed ID: 37149961
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Eating behavior during dexamethasone treatment in children with acute lymphoblastic leukemia.
    Warris LT; van den Akker ELT; Bierings MB; van den Bos C; Aarsen FK; Zwaan MC; Tissing WJE; Veening MA; Pieters R; van den Heuvel-Eibrink MM
    Pediatr Blood Cancer; 2017 Dec; 64(12):. PubMed ID: 28598548
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dexamethasone alters sleep and fatigue in pediatric patients with acute lymphoblastic leukemia.
    Hinds PS; Hockenberry MJ; Gattuso JS; Srivastava DK; Tong X; Jones H; West N; McCarthy KS; Sadeh A; Ash M; Fernandez C; Pui CH
    Cancer; 2007 Nov; 110(10):2321-30. PubMed ID: 17926333
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unraveling Dexamethasone-Induced Neurobehavioral and Sleep Problems in Children With ALL: Which Determinants Are Important?
    van Hulst AM; Grootenhuis MA; Verwaaijen EJ; van Litsenburg RRL; Li L; van Zelst BD; Broer L; Pluijm SMF; Pieters R; Fiocco M; van den Akker ELT; van den Heuvel-Eibrink MM
    JCO Precis Oncol; 2023 Jun; 7():e2200678. PubMed ID: 37343203
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of dexamethasone on sleep in young children with acute lymphoblastic leukemia.
    Rosen G; Harris AK; Liu M; Dreyfus J; Krueger J; Messinger YH
    Sleep Med; 2015 Apr; 16(4):503-9. PubMed ID: 25799940
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HRQOL implications of treatment with dexamethasone for children with acute lymphoblastic leukemia (ALL).
    Eiser C; Davies H; Jenney M; Stride C; Glaser A
    Pediatr Blood Cancer; 2006 Jan; 46(1):35-9. PubMed ID: 15926164
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dexamethasone-Induced Sarcopenia and Physical Frailty in Children With Acute Lymphoblastic Leukemia: Protocol for a Prospective Cohort Study.
    Verwaaijen EJ; van Hulst A; Fiocco M; Hartman A; Grootenhuis M; Pluijm S; Pieters R; van den Akker E; van den Heuvel-Eibrink MM
    JMIR Res Protoc; 2022 Apr; 11(4):e33517. PubMed ID: 35403603
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hydrocortisone as an Intervention for Dexamethasone-Induced Adverse Effects in Pediatric Patients With Acute Lymphoblastic Leukemia: Results of a Double-Blind, Randomized Controlled Trial.
    Warris LT; van den Heuvel-Eibrink MM; Aarsen FK; Pluijm SM; Bierings MB; van den Bos C; Zwaan CM; Thygesen HH; Tissing WJ; Veening MA; Pieters R; van den Akker EL
    J Clin Oncol; 2016 Jul; 34(19):2287-93. PubMed ID: 27161966
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of dexamethasone and prednisone on sleep in children with acute lymphoblastic leukemia.
    Daniel LC; Li Y; Kloss JD; Reilly AF; Barakat LP
    Support Care Cancer; 2016 Sep; 24(9):3897-906. PubMed ID: 27108263
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impairment in circadian activity rhythms occurs during dexamethasone therapy in children with leukemia.
    Rogers VE; Zhu S; Ancoli-Israel S; Hinds PS
    Pediatr Blood Cancer; 2014 Nov; 61(11):1986-91. PubMed ID: 25066691
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gender differences in sleep, fatigue, and daytime activity in a pediatric oncology sample receiving dexamethasone.
    Sanford SD; Okuma JO; Pan J; Srivastava DK; West N; Farr L; Hinds PS
    J Pediatr Psychol; 2008 Apr; 33(3):298-306. PubMed ID: 18024981
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predicting the neurobehavioral side effects of dexamethasone in pediatric acute lymphoblastic leukemia.
    Warris LT; van den Akker EL; Aarsen FK; Bierings MB; van den Bos C; Tissing WJ; Sassen SD; Veening MA; Zwaan CM; Pieters R; van den Heuvel-Eibrink MM
    Psychoneuroendocrinology; 2016 Oct; 72():190-5. PubMed ID: 27448086
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms of dexamethasone-induced disturbed sleep and fatigue in paediatric patients receiving treatment for ALL.
    Vallance K; Liu W; Mandrell BN; Panetta JC; Gattuso JS; Hockenberry M; Zupanec S; Yang L; Yang J; Hinds PS
    Eur J Cancer; 2010 Jul; 46(10):1848-55. PubMed ID: 20400291
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute Activation of Metabolic Syndrome Components in Pediatric Acute Lymphoblastic Leukemia Patients Treated with Dexamethasone.
    Warris LT; van den Akker EL; Bierings MB; van den Bos C; Zwaan CM; Sassen SD; Tissing WJ; Veening MA; Pieters R; van den Heuvel-Eibrink MM
    PLoS One; 2016; 11(6):e0158225. PubMed ID: 27362350
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of dexamethasone on quality of life in children with acute lymphoblastic leukaemia: a prospective observational study.
    de Vries MA; van Litsenburg RR; Huisman J; Grootenhuis MA; Versluys AB; Kaspers GJ; Gemke RJ
    Health Qual Life Outcomes; 2008 Nov; 6():103. PubMed ID: 19036151
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Relationship between body mass index and leptin levels in children treated for acute lymphoblastic leukemia during and after maintenance therapy].
    Muszyńska-Rosłan K; Krawczuk-Rybak M; Topczewska M; Sawicka-Zukowska M
    Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2006; 12(2):91-5. PubMed ID: 16813712
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.